Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Characterizing an outbreak of vancomycin-resistant enterococci using hidden Markov models.

E S McBryde1, A N Pettitt, B S Cooper

  • 1School of Mathematical Sciences, Queensland University of Technology, Brisbane, Queensland 4001, Australia. e.mcbryde@qut.edu.au

Journal of the Royal Society, Interface
|March 16, 2007
PubMed
Summary

A novel statistical model using hidden Markov models (HMMs) effectively distinguished epidemic from sporadic vancomycin-resistant enterococci (VRE) transmission. This method accurately estimated transmission dynamics, even with undetected cases, and validated against genotyping.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Key lessons from the COVID-19 public health response in Australia.

The Lancet regional health. Western Pacific·2022
Same author

Comparisons of statistical distributions for cluster sizes in a developing pandemic.

BMC medical research methodology·2022
Same author

Isotope Shifts of Radium Monofluoride Molecules.

Physical review letters·2021
Same author

Hospitalisation for lower respiratory tract infection is associated with an increased incidence of acute myocardial infarction and stroke in tropical Northern Australia.

Scientific reports·2021
Same author

Is Nigeria really on top of COVID-19? Message from effective reproduction number.

Epidemiology and infection·2020
Same author

eCertification (eCert).

Revue scientifique et technique (International Office of Epizootics)·2020

Area of Science:

  • Infectious disease epidemiology
  • Mathematical modeling in healthcare
  • Nosocomial pathogen surveillance

Background:

  • Antibiotic-resistant pathogens like vancomycin-resistant enterococci (VRE) pose significant healthcare challenges.
  • Distinguishing epidemic from sporadic VRE transmission is crucial for effective control.
  • Genotyping is a common but potentially resource-intensive method for VRE transmission analysis.

Purpose of the Study:

  • To develop and validate a statistical model for estimating VRE transmission characteristics.
  • To compare the performance of a hidden Markov model (HMM) against traditional genotyping methods.
  • To assess the utility of HMMs in analyzing serial prevalence data for nosocomial pathogens.

Main Methods:

  • A continuous-time hidden Markov model (HMM) was developed to analyze weekly VRE prevalence data over 157 weeks.

Related Experiment Videos

  • The model estimated parameters for ward cross-transmission and sporadic colonization.
  • Model performance was compared with concomitant genotyping (glycopeptide resistance genes) and pulsed-field gel electrophoresis (PFGE).
  • Main Results:

    • The HMM estimated that 89% of VRE transmissions were due to ward cross-transmission and 11% were sporadic.
    • Genotyping results showed high similarity (90% identical genes, 84% identical PFGE patterns) among cases.
    • The HMM identified a dynamic change in transmission rates, increasing before an outbreak and declining post-intervention, aligning with environmental decontamination efforts.

    Conclusions:

    • Hidden Markov models (HMMs) are effective for analyzing serial prevalence data to characterize nosocomial pathogen acquisition.
    • HMMs can accurately estimate transmission parameters, even with imperfect detection of colonized individuals.
    • The statistical approach provided comparable and complementary insights to genotyping, offering a robust method for VRE surveillance.